Rick Pauls
Chief Executive Officer at DIAMEDICA THERAPEUTICS INC.
Net worth: 284 329 $ as of 2024-03-30
Rick Pauls active positions
Companies | Position | Start | End |
---|---|---|---|
DIAMEDICA THERAPEUTICS INC. | Director/Board Member | 2014-07-09 | - |
Chief Executive Officer | 2009-12-31 | - | |
President | 2009-12-31 | - | |
Chairman | 2008-03-31 | 2014-07-09 |
Career history of Rick Pauls
Former positions of Rick Pauls
Companies | Position | Start | End |
---|---|---|---|
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Director/Board Member | 2009-08-26 | 2012-08-17 |
CentreStone Ventures, Inc.
CentreStone Ventures, Inc. Investment ManagersFinance CentreStone Ventures Inc (CentreStone) is an independent venture capital firm founded in 2004. The firm is headquartered in Winnipeg, Manitoba. | Private Equity Investor | 2001-12-31 | 2010-01-30 |
LED Medical Diagnostics, Inc. /Old/
LED Medical Diagnostics, Inc. /Old/ Medical DistributorsDistribution Services LED Medical Diagnostics, Inc. develops and markets medical screening devices. It provides detection of mucosal tissue abnormalities including malignant and pre malignant lesions to facilitate timely diagnosis and treatment based on a proprietary fluorescence visualization technology. The company was founded by Peter Whitehead in 2003 and is headquartered in Burnaby, Canada. | Director/Board Member | - | - |
Independent Dir/Board Member | - | - | |
APTERYX IMAGING INC. | Director/Board Member | 2008-10-14 | - |
Independent Dir/Board Member | 2012-08-06 | - | |
ALLY FINANCIAL INC. | Corporate Officer/Principal | - | - |
Training of Rick Pauls
University of Manitoba | Undergraduate Degree |
University of North Dakota | Masters Business Admin |
Statistics
International
United States | 5 |
Canada | 5 |
Operational
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Private Equity Investor | 1 |
Sectoral
Finance | 3 |
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ALLY FINANCIAL INC. | Finance |
DIAMEDICA THERAPEUTICS INC. | Health Technology |
Private companies | 4 |
---|---|
LED Medical Diagnostics, Inc. /Old/
LED Medical Diagnostics, Inc. /Old/ Medical DistributorsDistribution Services LED Medical Diagnostics, Inc. develops and markets medical screening devices. It provides detection of mucosal tissue abnormalities including malignant and pre malignant lesions to facilitate timely diagnosis and treatment based on a proprietary fluorescence visualization technology. The company was founded by Peter Whitehead in 2003 and is headquartered in Burnaby, Canada. | Distribution Services |
CentreStone Ventures, Inc.
CentreStone Ventures, Inc. Investment ManagersFinance CentreStone Ventures Inc (CentreStone) is an independent venture capital firm founded in 2004. The firm is headquartered in Winnipeg, Manitoba. | Finance |
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Health Services |
Apteryx Imaging, Inc.
Apteryx Imaging, Inc. Medical SpecialtiesHealth Technology Apteryx Imaging, Inc. engages in the provision of dental imaging technology software and systems. Its products include VELscope Vx, Xelis 3D Imaging Software, Imaging Cloud, Imaging Software, IC200 Intraoral Camera, 3Shape TRIOS Intraoral Scanners, RAYSCAN Alpha 3D, TUXEDO Intraoral Sensor and LED IC100 Intraoral Camera. The company was founded by Peter Whitehead on July 17, 2002 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Rick Pauls
- Experience